Analyst Expectations for Arrowhead Pharma's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published their opinion on Arrowhead Pharma (NASDAQ:ARWR) stock. The average price target for the stock has increased by 25.21% from the previous average price target of $51.33 to $64.27. The majority of the analysts are bullish on the stock.
July 21, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on Arrowhead Pharma (NASDAQ:ARWR) with an average price target of $64.27, indicating a potential upside.
The bullish sentiment among analysts, as well as the increased average price target, indicates a positive outlook for Arrowhead Pharma's stock. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100